Sina Rashedi on Fibrinolytic Therapies in Different Thromboembolic Diseases
Sina Rashedi, Postdoctoral Research Fellow at Brigham and Women’s Hospital, Harvard Medical School, reposted from Behnood Bikdeli on X:
”Thrilled to share our recent JACC Journals
State-of-the-Art Review on fibrinolytic therapies for different thromboembolic diseases
Grateful to the outstanding experts I had the privilege to learn from and collaborate with on this paper!”
Read the full article in JACC.
Article: Fibrinolytic Therapy for Thromboembolic Diseases: Approved Indications and Future Directions
Authors: Sina Rashedi, Hannah Leyva, Nada Hamade, Mariana B. Pfeferman, Luis Ortega-Paz, Parham Sadeghipour, Azita H. Talasaz, Michelle L. O’Donoghue, David Jimenez, Manuel Monrea, Christopher D. Anderson, Mitchell S.V. Elkind, Irene M. Lang, Jeffery I. Weitz, Samuel Z. Goldhaber, Raffaele De Caterina, Stavros V. Konstantinides, Gregory Piazza, Harlan M. Krumholz, Eugene Braunwald, and Behnood Bikdeli
Behnood Bikdeli, Cardiologist and Vascular medicine specialist at Brigham and Women’s Hospital and Harvard Medical School, shared on X:
”Fibrinolytic therapies for cardiovascular conditions :
In JACC Journals we show current use, RCT data on MI, PE, DVT, stroke, and future directions!”

Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
May 24, 2026, 16:12William Wallace: Normal B12 Levels May Still Cause Brain Damage and Cognitive Decline
-
May 24, 2026, 15:54Marc Carrier: Ottawa Race Weekend Raised Over 7,000 USD for Thrombosis Canada
-
May 24, 2026, 15:44Janak Sadhu: Building a Stroke-Free Mehsana Through Community Awareness and Healthcare Collaboration
-
May 24, 2026, 15:33Mohammed Zubair: AI-Driven Innovation in Stroke Diagnosis and Medical Imaging
-
May 24, 2026, 14:26Salome Mekhuzla: World Health Assembly Adopts Historic Global Resolution for Hemophilia and Bleeding Disorders
-
May 24, 2026, 13:10Thomas Pincez: Emerging Challenges in Sickle Cell Disease Gene Therapy and Cancer Risk
-
May 24, 2026, 12:04Kalpana Gupta Shekhawat: Ferritin Is More Than an Iron Marker
-
May 24, 2026, 11:50Peter Zdziarski: Making Rare Disease Research More Human
-
May 24, 2026, 11:39Bram Berkelmans: Donating with a View